ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for GENETIX BIOTHERAPEUTICS, INC. · Biotechnology and pharmaceutical company.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Medicare/Medicaid

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Health Issues

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Pharmacy

Issues related to regulatory incentives for rare disease therapies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.